Phase 2 study of dalantercept in recurrent or metastatic squamous cell carcinoma of the head and neck

被引：2
|
作者：
Jimeno, Antonio
Posner, Marshall R.
Weiss, Jared
Wirth, Lori J.
Saba, Nabil F.
Cohen, Roger B.
Popa, Elizabeta C.
Argiris, Athanassios
Grossmann, Kenneth F.
Sukari, Ammar
Korth, Chris
Wilson, Dawn
McClure, Ty
Alimzhanov, Marat
Pearsall, Scott
Attie, Kenneth M.
Sherman, Matthew L.
Pandya, Shuchi Sumant
机构：
[1] Univ Colorado Denver, Aurora, CO USA
[2] Icahn Sch Med Mt Sinai, Dept Hematol & Med Oncol, New York, NY 10029 USA
[3] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC USA
[4] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[5] Emory Univ, Atlanta, GA 30322 USA
[6] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[7] Weill Cornell Med Coll, New York, NY USA
[8] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[9] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[10] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[11] Acceleron Pharma, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.6045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6045
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Optimizing Treatment for Head and Neck Cancers: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    Haddad, Robert, I
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (07): : 982 - 984
  • [32] A phase II study of ispinesib in patients (PTS) with recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSC)
    Tang, Patricia
    Siu, Lillian L.
    Chen, Eric X.
    Hotte, Sebastien J.
    Chia, Stephen
    Schwarz, James K.
    Colevas, A. Dimitrios
    Johnson, Caitlin
    Pond, Greg R.
    Winquist, Eric
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 186 - 186
  • [33] Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma
    Shin, DM
    Khuri, FR
    Glisson, BS
    Ginsberg, L
    Papadimitrakopoulou, VM
    Clayman, G
    Lee, JJ
    Ang, KK
    Lippman, SM
    Hong, WK
    [J]. CANCER, 2001, 91 (07) : 1316 - 1323
  • [34] Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck
    Vermorken, J. B.
    Licitra, L.
    Stoehlmacher-Williams, J.
    Dietz, A.
    Lopez-Picazo, J. M.
    Hamid, O.
    Hossain, A. M.
    Chang, S. -C.
    Gauler, T. C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (13) : 2877 - 2883
  • [35] Docetaxel plus gemcitabine in recurrent and/or metastatic squamous cell carcinoma of the head and neck - A phase II multicenter study
    Labourey, Jean-Luc
    Cupissol, Didier
    Calais, Gilles
    Tourani, Jean-Marc
    Kohser, Frederic
    Borel, Christian
    Eymard, Jean-Christophe
    Germann, Nathalie
    Tubiana-Mathieu, Nicole
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (03): : 278 - 282
  • [36] Phase II study of vinorelbine (NVB) in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Degardin, M
    Bastit, P
    Rolland, F
    Armand, JP
    Chevallier, B
    VanGlabbeke, M
    Boudillet, J
    Tresca, P
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 843 - 843
  • [37] Phase I study of ribociclib plus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Seront, E.
    Schmitz, S.
    Rottey, S.
    Henry, S.
    Lonchay, C.
    van Caloen, G.
    Gilain, A.
    Machiels, J-P.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [38] A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma
    Dennis, Michael J.
    Sacco, Assuntina G.
    Qi, Yuchen
    Bykowski, Julie
    Pittman, Emily
    Chen, Ruifeng
    Messer, Karen
    Cohen, Ezra E. W.
    Gold, Kathryn A.
    [J]. ORAL ONCOLOGY, 2022, 135
  • [39] A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck
    Seiwert, T. Y.
    Fayette, J.
    Cupissol, D.
    del Campo, J. M.
    Clement, P. M.
    Hitt, R.
    Degardin, M.
    Zhang, W.
    Blackman, A.
    Ehrnrooth, E.
    Cohen, E. E. W.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (09) : 1813 - 1820
  • [40] A phase II trial of vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Saxman, S
    Mann, B
    Canfield, V
    Loehrer, P
    Vokes, E
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (04): : 398 - 400
12345